KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Cash & Current Investments (2016 - 2025)

Cvs Health (CVS) has disclosed Cash & Current Investments for 17 consecutive years, with $10.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments fell 3.59% year-over-year to $10.6 billion, compared with a TTM value of $10.6 billion through Dec 2025, down 3.59%, and an annual FY2025 reading of $10.6 billion, down 3.59% over the prior year.
  • Cash & Current Investments was $10.6 billion for Q4 2025 at Cvs Health, down from $11.2 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $20.0 billion in Q3 2022 and bottomed at $8.8 billion in Q1 2021.
  • Average Cash & Current Investments over 5 years is $13.4 billion, with a median of $12.7 billion recorded in 2021.
  • The sharpest move saw Cash & Current Investments tumbled 42.03% in 2021, then soared 56.23% in 2023.
  • Year by year, Cash & Current Investments stood at $12.5 billion in 2021, then grew by 25.53% to $15.7 billion in 2022, then fell by 27.14% to $11.5 billion in 2023, then dropped by 4.03% to $11.0 billion in 2024, then decreased by 3.59% to $10.6 billion in 2025.
  • Business Quant data shows Cash & Current Investments for CVS at $10.6 billion in Q4 2025, $11.2 billion in Q3 2025, and $14.2 billion in Q2 2025.